Protection from intestinal inflammation by bacterial exopolysaccharides

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• Commensal bacteria can modulate host inflammatory responses to pathogens.
• The mechanisms by which commensals prevent pathogenesis are not fully understood.
• Bacillus subtilis prevents Citrobacter rodentium-induced colitis in mice, with exopolysaccharides (EPS) identified as the key protective component.

Purpose of the Study:

• To investigate the role of Bacillus subtilis exopolysaccharides (EPS) in preventing Citrobacter rodentium-induced intestinal inflammation.
• To elucidate the molecular mechanisms underlying EPS-mediated protection.

Main Methods:

• Isolation and characterization of bacterial EPS.
• Administration of EPS to mice and subsequent challenge with Citrobacter rodentium.
• Assessment of disease severity and inflammation markers.
• Use of knockout mouse models (TLR4 and MyD88 signaling in myeloid cells).
• Adoptive transfer of peritoneal macrophages.

Main Results:

• Bacterial EPS administration prevented Citrobacter rodentium-associated intestinal disease.
• Protection was dependent on Toll-like receptor 4 (TLR4), as TLR4 knockout mice did not benefit from EPS treatment.
• Adoptive transfer of macrophages from EPS-treated mice conferred protection to wild-type recipients.
• EPS bind to peritoneal macrophages, and protection requires MyD88 signaling in myeloid cells.

Conclusions:

• Bacterial EPS are effective in preventing intestinal inflammation caused by enteric pathogens like Citrobacter rodentium.
• The protective mechanism involves TLR4-dependent signaling in myeloid cells, specifically macrophages.
• These findings suggest a simple strategy for preventing enteric pathogen-induced colitis.